IntellxxDNA® is a leader in genomic intelligence, aiming to make DNA-targeted precision medicine a reality for healthcare professionals. Founded in 2007, the company focuses on providing licensed healthcare professionals with accurate, accessible, and actionable genomic intelligence to support cutting-edge clinical decision-making. Their advanced research and proprietary methodology offer comprehensive information regarding genomic risks, benefits, and evidence-based potential intervention strategies. IntellxxDNA™, created by clinicians for clinicians, emphasizes gene-to-gene and gene-to-environment interactions through SNP technology. Their data and analytics delve into the intricacies of a patient’s genomic profile and the impact of small DNA variations on their health risks and quality of life. The company also provides evidence-based, well-researched potential intervention strategies across various elements such as environment, lifestyle, nutrition, supplements, and medications. Currently, there is no available information regarding the headquarter location or recent investments and investors. IntellxxDNA® operates within the Health Care and Information Technology industries, presenting an innovative stride in leveraging genomic data for clinical decision-making.
There is no investment information
No recent news or press coverage available for IntellxxDNA®.